SIMCERE PHARMAC. GRP LTD (S2P) — Cash Flow Quality Index
SIMCERE PHARMAC. GRP LTD (S2P) has a Cash Flow Quality Index of 1.50x as of December 2025. Operating cash flow of €2.01 Billion exceeds net income of €1.34 Billion, indicating high earnings quality where cash backs reported profits. Explore S2P operating cash flow to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
SIMCERE PHARMAC. GRP LTD Cash Flow Quality Index (2021–2025)
Historical Cash Flow Quality Index for SIMCERE PHARMAC. GRP LTD across 5 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check S2P cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for SIMCERE PHARMAC. GRP LTD (2021–2025)
Year-by-year earnings quality comparison for SIMCERE PHARMAC. GRP LTD. For live market cap and the full company financial profile, see SIMCERE PHARMAC. GRP LTD market capitalisation.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.50x | €2.01 Billion | €1.34 Billion | ▼ -89.1% |
| 2024 | 13.76x | €1.39 Billion | €101.13 Million | ▲ +804.2% |
| 2023 | 1.52x | €151.05 Million | €99.28 Million | ▼ -84.7% |
| 2022 | 9.97x | €1.35 Billion | €135.79 Million | ▲ +1268.6% |
| 2021 | -0.85x | €-201.97 Million | €236.69 Million | — |